Vitamin D immunoregulation through dendritic cells

Immunology

Volumn 148, Issue 3, 2016, Pages 227-236

  Bscheider, Michael ^a   Butcher, Eugene C ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

dendritic cells; inflammation; vitamin D

Indexed keywords

VITAMIN D;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; IN VIVO STUDY; INFLAMMATORY CELL; METABOLIC ACTIVATION; MONOCYTE; NONHUMAN; NUCLEAR REPROGRAMMING; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VITAMIN SUPPLEMENTATION; ANIMAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; VITAMIN D;

EID: 84975744163     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12610     Document Type: Review

References (80)

1. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31:563–604. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3853342&tool=pmcentrez&rendertype=abstract.
2. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015; 16:343–353.
3. Kiss M, Czimmerer Z, Nagy L. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: from physiology to pathology. J Allergy Clin Immunol 2013; 132:264–86. URL http://dx.doi.org/10.1016/j.jaci.2013.05.044.
4. Veldhoen M, Brucklacher-Waldert V. Dietary influences on intestinal immunity. Nat Rev Immunol 2012; 12:696–708. URL http://www.ncbi.nlm.nih.gov/pubmed/23007570.
5. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685–98. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2906676&tool=pmcentrez&rendertype=abstract.
6. Zeng R, Bscheider M, Lahl K, Lee M, Butcher EC. Generation and transcriptional programming of intestinal dendritic cells: essential role of retinoic acid. Mucosal Immunol 2015; 9:183–193.
7. Spencer SP, Wilhelm C, Yang Q, Hall J a, Bouladoux N, Boyd a et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 2014; 343:432–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24458645.
8. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357:266–81.
9. Yang C-Y, Leung PSC, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 2013; 45:217–26. URL http://www.ncbi.nlm.nih.gov/pubmed/23359064.
10. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010;2373–83.
11. van Brussel I, Lee WP, Rombouts M, Nuyts AH, Heylen M, de Winter BY et al. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality? Autoimmun Rev 2014; 13:138–50. URL http://dx.doi.org/10.1016/j.autrev.2013.09.008.
12. Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys 2012; 523:95–102. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3361592&tool=pmcentrez&rendertype=abstract.
13. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 2011; 11:584–96. URL http://dx.doi.org/10.1038/nri3045.
14. Nikolic T, Roep BO. Regulatory multitasking of tolerogenic dendritic cells – lessons taken from vitamin d3-treated tolerogenic dendritic cells. Front Immunol 2013; 4:113. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3653108&tool=pmcentrez&rendertype=abstract.
15. Hewison M, Adams JS. Extrarenal 1a-hydroxylase. Vitam D 2011;777–804.URL http://www.crossref.org/deleted_DOI.html
16. Adorini L. Control of adaptive immunity by vitamin D receptor agonists [Internet]. 3rd edn. Vitamin D. Elsevier 2011. 1789–809pp. URL http://dx.doi.org/10.1016/B978-0-12-381978-9.10092-7.
17. Barragan M, Good M, Kolls J. Regulation of dendritic cell function by vitamin D. Nutrients 2015; 7:8127–51. URL http://www.mdpi.com/2072-6643/7/9/5383/.
18. Adorini L, Penna G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol 2009; 188:251–73.
19. Romani N, Gruner S, Brang D, Eckhart K, Lenz A, Trockenbacher B et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180:83–93.
20. Penna G, Adorini L. 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405–11. URL http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.164.5.2405.
21. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli A M, Adorini L. Regulatory T cells induced by 1,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167:1945–53. URL http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.167.4.1945.
22. Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2006; 178:145–53. URL http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.178.1.145.
23. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG et al. Differential regulation of vitamin d receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170:5382–90. URL http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.170.11.5382.
24. Van Halteren AGS, Van Etten E, De Jong EC, Bouillon R, Roep BO, Mathieu C. Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D3. Diabetes 2002; 51:2119–25.
25. Pearce EJ, Everts B.Dendritic cell metabolism. Nat Publ Gr [Internet]. Nature Publishing Group 2015;15:18–29. URL http://dx.doi.org/10.1038/nri3771.
26. Heiden MG Vander, Cantley LC, Thompson CB, Mammalian P, Exhibit C, Metabolism A. Understanding the Warburg Effect: cell proliferation. Science 2009; 324:1029–34.
27. Pearce E, Pearce E. Metabolic pathways in immune cell activation and quiescence. Immunity 2013; 38:633–43. URL http://dx.doi.org/10.1016/j.immuni.2013.04.005.
28. Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, Deberardinis RJ et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010; 115:4742–9.
29. Everts B, Amiel E, Van Der Windt GJW, Freitas TC, Chott R, Yarasheski KE et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 2012; 120:1422–31.
30. Everts B, Amiel E, Huang SC-C, Smith AM, Chang C-H, Lam WY et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat Immunol 2014; 15:323–32. URL http://www.ncbi.nlm.nih.gov/pubmed/24562310.
31. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed a, Jiang J et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 1998; 95:2492–7. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19387&tool=pmcentrez&rendertype=abstract.
32. Ferreira GB, Vanherwegen A-S, Eelen G, Gutiérrez ACF, Van Lommel L, Marchal K et al. Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep [Internet]. 2015;10:711–25. URL http://linkinghub.elsevier.com/retrieve/pii/S2211124715000261.
33. Ferreira GB, Overbergh L, Verstuyf A, Mathieu C. 1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study. J Steroid Biochem Mol Biol 2013; 136:160–5. URL http://www.ncbi.nlm.nih.gov/pubmed/23098690.
34. Ferreira GB, Van Etten E, Lage K, Hansen DA, Moreau Y, Workman CT, et al. Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 2009; 9:3752–64.
35. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33:375–86.
36. Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization [Internet]. Annual review of immunology. 2015. 643–75 pp. URL http://www.annualreviews.org/doi/abs/10.1146/annurev-immunol-032414-112220.
37. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M et al. Origin of the lamina propria dendritic cell network. Immunity [Internet]. Elsevier Ltd 2009. 31:513–25. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2778256&tool=pmcentrez&rendertype=abstract.
38. Watchmaker PB, Lahl K, Lee M, Baumjohann D, Morton J, Kim SJ et al. Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. Nat Immunol 2014; 15:98–108. URL http://www.ncbi.nlm.nih.gov/pubmed/24292363.
39. + monocytes and licenses autoimmunity. Immunity 2015; 43:1–13. URL http://linkinghub.elsevier.com/retrieve/pii/S1074761315003222.
40. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008; 194:7–17.
41. Soilu-Hanninen M, Aivo J, Lindstrom B-M, Elovaara I, Sumelahti M-L, Farkkila M et al. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon-1β in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2012; 83:565–71. URL http://jnnp.bmj.com/cgi/doi/10.1136/jnnp-2011-301876.
42. Hettinger J, Richards DM, Hansson J, Barra MM, Joschko A-C, Krijgsveld J et al. Origin of monocytes and macrophages in a committed progenitor. Nat Immunol 2013; 14:821–30. URL http://www.ncbi.nlm.nih.gov/pubmed/23812096.
43. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 2014; 14:571–8. URL http://www.ncbi.nlm.nih.gov/pubmed/25033907.
44. + macrophages and dendritic cells. Immunity 2015; 42:1197–211. URL http://linkinghub.elsevier.com/retrieve/pii/S1074761315002162.
45. Gao Y, Nish S, Jiang R, Hou L, Licona-Limón P, Weinstein J et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 2013; 39:722–32.
46. Vander Lugt B, Khan A a, Hackney J a, Agrawal S, Lesch J, Zhou M et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol 2014; 15:161–7 URL http://www.ncbi.nlm.nih.gov/pubmed/24362890.
47. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 2001; 98:6800–5.
48. Oderup C, LaJevic M, Butcher EC. Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance. J Immunol 2013; 190:6126–34. URL http://www.ncbi.nlm.nih.gov/pubmed/23677472.
49. Zeng R, Oderup C, Yuan R, Lee M, Habtezion a, Hadeiba H et al. Retinoic acid regulates the development of a gut-homing precursor for intestinal dendritic cells. Mucosal Immunol 2013; 6:847–56. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3612556&tool=pmcentrez&rendertype=abstract.
50. Klebanoff C a, Spencer SP, Torabi-Parizi P, Grainger JR, Roychoudhuri R, Ji Y et al. Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J Exp Med 2013; 210:1961–76. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3782040&tool=pmcentrez&rendertype=abstract.
51. Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009; 2:340–50. URL http://dx.doi.org/10.1038/mi.2009.13.
52. Molenaar R, Knippenberg M, Goverse G, Olivier BJ, de Vos AF, O'Toole T et al. Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gut-draining lymph node stromal cells is controlled by dietary vitamin A. J Immunol 2011; 186:1934–42. URL http://www.ncbi.nlm.nih.gov/pubmed/21220692.
53. + dendritic cells with the ability to generate gut-tropic T cells. Mucosal Immunol 2014; 4:438–47. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3130189&tool=pmcentrez&rendertype=abstract.
54. Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 2013; 143:1679–86.
55. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29:726–76. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2583388&tool=pmcentrez&rendertype=abstract.
56. Wu S, Liao AP, Xia Y, Li YC, Li J-D, Sartor RB et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-κB activity in intestine. Am J Pathol 2010; 177:686–97. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2913341&tool=pmcentrez&rendertype=abstract.
57. Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 2013; 39:38–48. URL http://dx.doi.org/10.1016/j.immuni.2013.07.004.
58. + dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 2012; 209:935–45. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3348099&tool=pmcentrez&rendertype=abstract.
59. Ferreira GB, Gysemans C a, Demengeot J, da Cunha JPMCM, Vanherwegen A-S, Overbergh L et al. 1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. J Immunol 2014; 192:4210–20. URL http://www.ncbi.nlm.nih.gov/pubmed/24663679.
60. Lee J, Breton G, Oliveira TYK, Zhou YJ, Aljoufi a., Puhr S et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med 2015; 212:385–399. URL http://www.jem.org/cgi/doi/10.1084/jem.20141442.
61. + dendritic cells. J Exp Med 2015; 212:401–413. URL http://www.jem.org/cgi/doi/10.1084/jem.20141441.
62. Caspi RR. Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol 2008; 8:970–6.
63. Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin d receptor and T cell function. Front Immunol 2013; 4:148. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3684798&tool=pmcentrez&rendertype=abstract.
64. Cantorna MT, Waddell A. The vitamin D receptor turns off chronically activated T cells. Ann N Y Acad Sci 2014; 1317:70–5. URL http://www.ncbi.nlm.nih.gov/pubmed/24673331.
65. Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM et al. Lineage-specific effects of 1,25-dihydroxyvitamin D3 on the development of effector CD4 T cells. J Biol Chem 2011; 286:997–1004. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3020784&tool=pmcentrez&rendertype=abstract.
66. Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 2008; 9:981–7. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3171274&tool=pmcentrez&rendertype=abstract.
67. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D et al. DCs metabolize sunlight-induced vitamin D3 to “program” T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8:285–93. URL http://www.ncbi.nlm.nih.gov/pubmed/17259988.
68. Kundu R, Chain BM, Coussens AK, Khoo B, Noursadeghi M. Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. Eur J Immunol 2014; 44:1781–90. URL http://www.ncbi.nlm.nih.gov/pubmed/24643654.
69. Széles L, Keresztes G, Töröcsik D, Balajthy Z, Krenács L, Póliska S et al. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 2009; 182:2074–83.
70. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol 2012; 189:5155–64. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3504609&tool=pmcentrez&rendertype=abstract.
71. Enioutina EYY, Bareyan D, Daynes R a. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 2009; 182:4296–305. URL http://www.ncbi.nlm.nih.gov/pubmed/19299729.
72. Sun C-M, Hall J a, Blank RB, Bouladoux N, Oukka M, Mora JR et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204:1775–85. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2118682&tool=pmcentrez&rendertype=abstract.
73. Daynes RA, Enioutina EY, Butler S, Mu HH, McGee ZA, Araneo BA. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun 1996; 64:1100–9.
74. Enioutina EY, Bareyan D, Daynes RA. Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine 2007; 25:1236–49.
75. Enioutina EY, Bareyan D, Daynes RA. TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 2008; 26:601–13. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2632860&tool=pmcentrez&rendertype=abstract
76. + cells are a transient population of monocyte-derived macrophages. Immunity 2014; 41:465–77. URL http://linkinghub.elsevier.com/retrieve/pii/S1074761314003008.
77. + regulatory T cells. Hum Vaccines Immunother 2015; 9:250–8.
78. + myeloid dendritic cells acquire a high level of retinoic acid-producing capacity in response to vitamin D₃. J Immunol 2013; 191:3152–60. URL http://www.ncbi.nlm.nih.gov/pubmed/23966631.
79. Chang S-Y, Cha H-R, Chang J-H, Ko H-J, Yang H, Malissen B et al. Lack of retinoic acid leads to increased langerin-expressing dendritic cells in gut-associated lymphoid tissues. Gastroenterology 2010; 138:1468–78. URL http://www.ncbi.nlm.nih.gov/pubmed/19914251.
80. Schlitzer A, Sivakamasundari V, Chen J, Sumatoh HRB, Schreuder J, Lum J et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat Immunol 2015; 16:718–28. URL http://www.nature.com/doifinder/10.1038/ni.3200.